The estimated Net Worth of Raymond C Stevens is at least 3.19 百万$ dollars as of 25 January 2023. Raymond Stevens owns over 8,410 units of Danaher stock worth over 2,889,516$ and over the last 8 years he sold DHR stock worth over 0$. In addition, he makes 299,078$ as Independent Director at Danaher.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Raymond Stevens DHR stock SEC Form 4 insiders trading
Raymond has made over 1 trades of the Danaher stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 8,410 units of DHR stock worth 851,681$ on 25 January 2023.
The largest trade he's ever made was exercising 8,410 units of Danaher stock on 25 January 2023 worth over 851,681$. On average, Raymond trades about 216 units every 0 days since 2017. As of 25 January 2023 he still owns at least 10,624 units of Danaher stock.
You can see the complete history of Raymond Stevens stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Raymond Stevens biography
Prof. Raymond C. Stevens, Ph.D. is Independent Director of the Company. Professor Stevens has served as Provost Professor of Biological Sciences and Chemistry, and Director of The Bridge Institute, at the University of Southern California, a private research university, since July 2014, and as Chief Executive Officer of ShouTi, a biotechnology company, since May 2019. From 1999 until July 2014, he served as Professor of Molecular Biology and Chemistry with The Scripps Research Institute, a non-profit research organization. Professor Stevens is also Founding Director of the iHuman Institute at ShanghaiTech University, and has launched multiple biotechnology companies focused on drug discovery.
What is the salary of Raymond Stevens?
As the Independent Director of Danaher, the total compensation of Raymond Stevens at Danaher is 299,078$. There are 15 executives at Danaher getting paid more, with Rainer Blair having the highest compensation of 7,178,650$.
How old is Raymond Stevens?
Raymond Stevens is 56, he's been the Independent Director of Danaher since 2017. There are 12 older and 12 younger executives at Danaher. The oldest executive at Danaher Corp. is John Schwieters, 80, who is the Independent Director.
What's Raymond Stevens's mailing address?
Raymond's mailing address filed with the SEC is 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON, DC, 20037.
Insiders trading at Danaher
Over the last 20 years, insiders at Danaher have traded over 2,183,160,204$ worth of Danaher stock and bought 226,618 units worth 34,863,916$ . The most active insiders traders include Steven M Rales、Mitchell P Rales、Robert J Hugin. On average, Danaher executives and independent directors trade stock every 14 days with the average trade being worth of 25,840,276$. The most recent stock trade was executed by Georgeann Couchara on 26 August 2024, trading 952 units of DHR stock currently worth 255,488$.
What does Danaher do?
Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.
What does Danaher's logo look like?
Complete history of Raymond Stevens stock trades at Danaher
Danaher executives and stock owners
Danaher executives and other stock owners filed with the SEC include:
-
Rainer Blair,
President, Chief Executive Officer, Director -
Daniel Comas,
Executive Vice President -
Joakim Weidemanis,
Executive Vice President -
Matthew McGrew,
Chief Financial Officer, Executive Vice President -
Angela Lalor,
Senior Vice President - Human Resources -
Rainer M. Blair,
Pres, CEO & Director -
Brian Ellis,
Senior Vice President, Chief Compliance Officer, General Counsel -
Angela S. Lalor,
Sr. VP of HR -
Joakim Weidemanis,
Exec. VP -
Matthew R. McGrew,
CFO & Exec. VP -
Brian W. Ellis,
Sr. VP, Gen. Counsel & Chief Compliance Officer -
John Schwieters,
Independent Director -
Elias Zerhouni,
Independent Director -
Linda Hefner Filler,
Lead Independent Director -
Walter Lohr,
Independent Director -
Raymond Stevens,
Independent Director -
Alan Spoon,
Independent Director -
Teri List-Stoll,
Independent Director -
Pardis Sabeti,
Independent Director -
Jessica Mega,
Independent Director -
Mitchell P. Rales,
Co-Founder & Director -
Steven M. Rales,
Co-Founder & Chairman -
Mitchell Rales,
Director -
Daniel Raskas,
Senior Vice President - Corporate Development -
William King,
Senior Vice President - Strategic Development -
Robert Lutz,
Senior Vice President, Chief Accounting Officer -
Steven Rales,
Chairman of the Board -
Matthew E. Gugino C.F.A., CPA,
VP of Investor Relations and FP&A -
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.,
Sr. VP & Chief Science Officer -
Christopher M. Bouda,
Chief Accounting Officer -
Teri List,
Director -
Robert J Hugin,
Director -
Donald J Ehrlich,
Director -
William K Daniel,
EVP -
Thomas Patrick Jr Joyce,
President and CEO -
Christopher Paul Riley,
Executive Vice President -
Jonathan P Graham,
Senior VP & GC -
Montgomery Julie A Sawyer,
Executive Vice President -
H Lawrence Jr Culp,
President and CEO -
Philip Knisely,
Executive Vice President -
Mortimer M Caplin,
Director -
A Emmet Jr Stephenson,
Director -
James H Ditkoff,
Senior VP-Tax & Finance -
Steve Simms,
Executive Vice President -
Patrick W Allender,
Executive VP -
Daniel A Pryor,
VP-Strategic Development -
Mark A Beck,
Executive Vice President -
James A Lico,
Executive Vice President -
Georgeann Couchara,
SVP, Human Resources -
Feroz Dewan,
Director -
Jennifer Honeycutt,
Executive Vice President -
A Shane Sanders,
Director -
Christopher Bouda,
VP, Chief Accounting Officer -
Jose Carlos Gutierrez Ramos,
SVP, Chief Science Officer